Teva Pharma (NYSE: TEVA) and Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) announce that the companies have entered into an exclusive license ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE